Exact Mass: 466.2943758

Exact Mass Matches: 466.2943758

Found 466 metabolites which its exact mass value is equals to given mass value 466.2943758, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cephaeline

(1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C28H38N2O4 (466.2831428)


Cephaeline is a pyridoisoquinoline comprising emetam having a hydroxy group at the 6-position and methoxy substituents at the 7-, 10- and 11-positions. It derives from a hydride of an emetan. Cephaeline is a natural product found in Dorstenia psilurus, Pogonopus tubulosus, and other organisms with data available. Cephaeline is an alkaloid compound that belongs to the isoquinoline alkaloid family. It is naturally found in certain plant species, particularly those of the Cephalotaxus genus, which includes trees and shrubs native to East Asia and the Himalayas. Cephaeline is known for its pharmacological properties and has been the subject of various studies for its potential therapeutic applications. Chemically, cephaeline has a complex structure characterized by an isoquinoline core with additional functional groups attached. It is classified as a monoterpenoid indole alkaloid, reflecting its biosynthetic origin from the amino acid tryptophan. The presence of these functional groups contributes to its biological activity and pharmacological effects. In terms of its physical properties, cephaeline is typically a crystalline solid with a defined melting point. It is slightly soluble in water but more soluble in organic solvents, which is common for alkaloids of its class. The exact color and solubility characteristics can vary depending on the presence of impurities or derivatives. Cephaeline has been of interest in the field of pharmacognosy and drug discovery due to its potential therapeutic effects, including anti-cancer, anti-inflammatory, and neuroprotective properties. However, further research is needed to fully understand its mechanisms of action and potential uses in medicine. Annotation level-1 (-)-Cephaeline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=483-17-0 (retrieved 2024-07-12) (CAS RN: 483-17-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Androsterone glucuronide

(2S,3S,4S,5R,6R)-6-{[(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93\\% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522) [HMDB] Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93\\% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Cholesterol sulfate

[(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid

C27H46O4S (466.31166360000003)


Cholesterol sulfate, or cholest-5-en-3beta-ol sulfate, is an endogenous steroid and the C3beta sulfate ester of cholesterol. It is formed from cholesterol by steroid sulfotransferases (SSTs) such as SULT2B1b (also known as cholesterol sulfotransferase) and is converted back into cholesterol by steroid sulfatase (STS). Accumulation of cholesterol sulfate in the skin is implicated in the pathophysiology of X-linked ichthyosis, a congenital disorder in which STS is non-functional and the body cannot convert cholesterol sulfate back into cholesterol. Cholesterol sulfate is quantitatively the most important known sterol sulfate in human plasma, where it is present in a concentration that overlaps that of the other abundant circulating steroid sulfate, dehydroepiandrosterone (DHEA) sulfate (PMID 12730293). Cholesterol sulfate has a stabilizing function on the membrane, supports platelet adhesion and is involved in signal transduction (PMID 12730293). It plays a role in protecting erythrocytes from osmotic lysis and regulating sperm capacitation. Cholesterol sulfate can regulate the activity of serine proteases, e.g., those involved in blood clotting, fibrinolysis, and epidermal cell adhesion (PMID 12730293). As a result of its ability to regulate the activity of selective protein kinase C isoforms and modulate the specificity of phosphatidylinositol 3-kinase, cholesterol sulfate is involved in signal transduction (PMID 12730293). Cholesterol sulfate functions in keratinocyte differentiation, inducing genes that encode for key components involved in development of the barrier (PMID 12730293). Cholesterol sulfate is a sterol sulfate in human plasma. It is a component of cell membrane and has a regulatory function. It has a stabilizing function on the membrane, supports platelet adhesion and involves in signal transduction. (PMID 12730293) [HMDB] D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

5β-Androstan-3α-ol-17-One Glucosiduronate

(2S,3S,4S,5R,6R)-6-{[(1S,2S,5R,7R,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Etiocholanolone glucuronide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=3602-09-3 (retrieved 2024-06-29) (CAS RN: 3602-09-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

5-alpha-Dihydrotestosterone glucuronide

(2S,3S,4S,5R,6R)-6-{[(1S,2S,7S,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

TetraHCA

3-hydroxy-2-methyl-6-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}heptanoic acid

C27H46O6 (466.3294216)


TetraHCA is considered to be practically insoluble (in water) and acidic

   

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

(3S,5R,6S)-6-{[(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

1-eicosanoyl-glycero-3-phosphate

[(2R)-2-hydroxy-3-(icosanoyloxy)propoxy]phosphonic acid

C23H47O7P (466.3059242)


1-eicosanoyl-glycero-3-phosphate is also known as LPA(20:0/0:0). 1-eicosanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-eicosanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

   

LysoPA(i-20:0/0:0)

{2-hydroxy-3-[(18-methylnonadecanoyl)oxy]propoxy}phosphonic acid

C23H47O7P (466.3059242)


LysoPA(i-20:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-20:0/0:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

   

N-Linoleoyl Tryptophan

3-(1H-indol-3-yl)-2-(octadeca-9,12-dienamido)propanoic acid

C29H42N2O3 (466.31952620000004)


N-linoleoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

5alpha-Androstan-17beta-ol-3-one glucosiduronate

6-({2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


   

Acetildenafil

1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate

C25H34N6O3 (466.2692254)


   

Cephaeline

1-({3-ethyl-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl}methyl)-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C28H38N2O4 (466.2831428)


   

Cholesterol phosphate

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dihydrogen phosphate

C27H47O4P (466.3211792)


   

Mutant IDH1 inhibitor

3-{2-[(1-{4-[(4-acetylpiperazin-1-yl)methyl]phenyl}ethyl)amino]pyrimidin-4-yl}-4-(propan-2-yl)-1,3-oxazolidin-2-one

C25H34N6O3 (466.2692254)


   

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6R,7Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2566548)


DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,6S,7Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2566548)


DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2566548)


DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2566548)


DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

28-Norbrassinolide

(1S,2R,4R,5S,7S,11S,12S,15R,16S)-15-[(2S,3R,4R)-3,4-dihydroxy-6-methylheptan-2-yl]-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0²,⁷.0¹²,¹⁶]octadecan-8-one

C27H46O6 (466.3294216)


28-norbrassinolide belongs to brassinolides and derivatives class of compounds. Those are cholestane based steroid lactones containing benzo[c]indeno[5,4-e]oxepin-3-one. 28-norbrassinolide is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 28-norbrassinolide can be found in tea and turnip, which makes 28-norbrassinolide a potential biomarker for the consumption of these food products.

   

cholesterol sulfate

cholesterol sulfate

C27H46O4S (466.31166360000003)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors A steroid sulfate that is cholesterol substituted by a sulfoxy group at position 3. D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   
   
   
   

Certonardosterol A4

Certonardosterol A4

C27H46O6 (466.3294216)


   
   
   

(-)-5alpha-(12-Cytisinylmethyl)-6alpha-hydroxylupanine

(-)-5alpha-(12-Cytisinylmethyl)-6alpha-hydroxylupanine

C27H38N4O3 (466.2943758)


   
   

2,2,6a,6b,9,9,12a-heptamethyl-3,10-dioxo-1,4,5,6,6a,7,8,8a,11,12-decahydropicene-4a-carboxylic acid

2,2,6a,6b,9,9,12a-heptamethyl-3,10-dioxo-1,4,5,6,6a,7,8,8a,11,12-decahydropicene-4a-carboxylic acid

C30H42O4 (466.30829320000004)


   
   
   

N-(12-Amino-4,9-diazadodecan-1-yl)-2-[[(2,4-dihydroxyphenyl)acetyl]amino]succinamide

N-(12-Amino-4,9-diazadodecan-1-yl)-2-[[(2,4-dihydroxyphenyl)acetyl]amino]succinamide

C22H38N6O5 (466.2903538)


   
   
   

Mastigophorene D

[S-(R*,R*)]-4,4-(1,2-Ethanediyl)bis[6-(1,2,2-trimethylcyclopentyl)-1,2-benzenediol

C30H42O4 (466.30829320000004)


   
   

Kleinioxanthrone 2

Kleinioxanthrone 2

C29H38O5 (466.2719098)


   

Mastigophorene C

[S-(R*,R*)]-3-[[3,4-Dihydroxy-5-(1,2,2-trimethylcyclopentyl)phenyl]methyl]-4-methyl-6-(1,2,2-trimethylcyclopentyl)-1,2-benzenediol

C30H42O4 (466.30829320000004)


   
   
   
   

Chabrolonaphthoquinone B

Chabrolonaphthoquinone B

C29H38O5 (466.2719098)


   
   
   
   

Methyl 15-cinnamoyloxy-7-labden-17-oate

Methyl 15-cinnamoyloxy-7-labden-17-oate

C30H42O4 (466.30829320000004)


   

acetildenafil

acetildenafil

C25H34N6O3 (466.2692254)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   
   

Dimethyl acetildenafil

Dimethyl acetildenafil

C25H34N6O3 (466.2692254)


   

1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N2-methylalaninamide

1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N2-methylalaninamide

C23H38N4O6 (466.2791208)


   

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-11-ol|Usambaridin Br|Usambaridine Br

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-11-ol|Usambaridin Br|Usambaridine Br

C30H34N4O (466.2732474)


   
   

10-Hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-10-ol|18-Dehydro-10-hydroxynigritanin

10-Hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-10-ol|18-Dehydro-10-hydroxynigritanin

C30H34N4O (466.2732474)


   

(11alpha,12alpha)-4-demethyl-11,12-epoxy-3,13-dihydroxy-2-oxoursa-3,20(30)-diene-28-oic acid gamma-lactone|adenanthusone

(11alpha,12alpha)-4-demethyl-11,12-epoxy-3,13-dihydroxy-2-oxoursa-3,20(30)-diene-28-oic acid gamma-lactone|adenanthusone

C29H38O5 (466.2719098)


   
   

(3alpha,5beta,7alpha,12alpha)-form-3,7,12,27-Tetrahydroxycholesten-26-oic acid

(3alpha,5beta,7alpha,12alpha)-form-3,7,12,27-Tetrahydroxycholesten-26-oic acid

C27H46O6 (466.3294216)


   

Isovaleryl-coladonin

Isovaleryl-coladonin

C29H38O5 (466.2719098)


   

(1S,2S,3R,4R,6R)-diangeloyloxy-3,4-epoxy-2,10,11-trihydroxybisabol-7(14)-ene|1beta,8-diangeloyloxy-3beta,4beta-epoxy-2beta,10,11-trihydroxybisabol-7(14)-ene

(1S,2S,3R,4R,6R)-diangeloyloxy-3,4-epoxy-2,10,11-trihydroxybisabol-7(14)-ene|1beta,8-diangeloyloxy-3beta,4beta-epoxy-2beta,10,11-trihydroxybisabol-7(14)-ene

C25H38O8 (466.2566548)


   

Varanic acid

3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

8alpha-hydroxylabda-13(16),14-dien-19-yl (Z)-4-hydroxycinnamate

8alpha-hydroxylabda-13(16),14-dien-19-yl (Z)-4-hydroxycinnamate

C29H38O5 (466.2719098)


   

2,22beta-dihydroxy-3-methoxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione

2,22beta-dihydroxy-3-methoxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione

C29H38O5 (466.2719098)


   

3-methyl-23-hydroxy-6-oxo-tingenol|3-O-methyl-23-hydroxy-6-oxotingenol

3-methyl-23-hydroxy-6-oxo-tingenol|3-O-methyl-23-hydroxy-6-oxotingenol

C29H38O5 (466.2719098)


   
   
   
   

23,27-Epoxy-3-oxolanosta-7,23,25(27)-trien-26-oic acid|Pseudolarifuroic acid

23,27-Epoxy-3-oxolanosta-7,23,25(27)-trien-26-oic acid|Pseudolarifuroic acid

C30H42O4 (466.30829320000004)


   
   
   

8alpha-hydroxylabda-13(16),14-dien-19-yl p-methoxycinnamate

8alpha-hydroxylabda-13(16),14-dien-19-yl p-methoxycinnamate

C30H42O4 (466.30829320000004)


   
   

7,8-Dihydroecdyson, Cheilanthon A

7,8-Dihydroecdyson, Cheilanthon A

C27H46O6 (466.3294216)


   
   

(24S)-3beta,4beta,6alpha,8,24-pentahydroxy-5alpha-cholestan-15-one|certonardosterol Q2

(24S)-3beta,4beta,6alpha,8,24-pentahydroxy-5alpha-cholestan-15-one|certonardosterol Q2

C27H46O6 (466.3294216)


   
   

16(R)-6alpha,11beta-dihydroxy-17-methoxy-3beta,7beta-diacetoxy-ent-kaur-15-one|xindongnin G

16(R)-6alpha,11beta-dihydroxy-17-methoxy-3beta,7beta-diacetoxy-ent-kaur-15-one|xindongnin G

C25H38O8 (466.2566548)


   

ent-manool-13-O-beta-D-4-acetylxylopyranoside

ent-manool-13-O-beta-D-4-acetylxylopyranoside

C27H46O6 (466.3294216)


   
   

certonardosterol K

certonardosterol K

C27H46O6 (466.3294216)


   

14,15,18-triacetyl-trinertetrol

14,15,18-triacetyl-trinertetrol

C26H42O7 (466.2930382)


   
   

clerodinin A|clerodinin B|lupulin D|O15-De-Et,O15-Methyl,15-Epimer-Clerodinin C

clerodinin A|clerodinin B|lupulin D|O15-De-Et,O15-Methyl,15-Epimer-Clerodinin C

C25H38O8 (466.2566548)


   

20-Hydroxyecdysone

20-Hydroxyecdysone

C26H42O7 (466.2930382)


   

(1R*,2R*,3E,7E,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,7-dien-2,16,18-triol

(1R*,2R*,3E,7E,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,7-dien-2,16,18-triol

C26H42O7 (466.2930382)


   

11,12-Di-O-acetyl-marsectohexol|11,12-di-O-acetylmarsectohexol|11.12-Di-O-acetyl-marsectohexol|12-O-acetyllanceogenin

11,12-Di-O-acetyl-marsectohexol|11,12-di-O-acetylmarsectohexol|11.12-Di-O-acetyl-marsectohexol|12-O-acetyllanceogenin

C25H38O8 (466.2566548)


   
   

(3beta, 5alpha, 6alpha, 24E)-Cholest-24-ene-3, 6, 8, 14, 15, 26-hexol, 9CI

(3beta, 5alpha, 6alpha, 24E)-Cholest-24-ene-3, 6, 8, 14, 15, 26-hexol, 9CI

C27H46O6 (466.3294216)


   
   
   

1,6,9-trihydroxy-3-(1-hydroxy-1-methylethyl)-10-isobutyryl-5,5-dimethyl-8-(3-methylbut-2-enyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione|garcinielliptone HF

1,6,9-trihydroxy-3-(1-hydroxy-1-methylethyl)-10-isobutyryl-5,5-dimethyl-8-(3-methylbut-2-enyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione|garcinielliptone HF

C25H38O8 (466.2566548)


   
   

(1beta,2beta,3beta,4beta,6beta)-3,4-epoxybisabol-7(14)-ene-1,2,8,10,11-pentol 2,10-diangelate|(2Z)-2-methylbut-2-enoic acid (1RS,2SR,3SR,4RS,6RS)-4-(2,5-dihydroxy-5-methyl-1-methylene-4-{[(2Z)-2-methyl-1-oxobut-2-en-1-yl]oxy}hexyl)-3-hydroxy-1-methyl-7-oxabicyclo[4.1.0]hept-2-yl ester

(1beta,2beta,3beta,4beta,6beta)-3,4-epoxybisabol-7(14)-ene-1,2,8,10,11-pentol 2,10-diangelate|(2Z)-2-methylbut-2-enoic acid (1RS,2SR,3SR,4RS,6RS)-4-(2,5-dihydroxy-5-methyl-1-methylene-4-{[(2Z)-2-methyl-1-oxobut-2-en-1-yl]oxy}hexyl)-3-hydroxy-1-methyl-7-oxabicyclo[4.1.0]hept-2-yl ester

C25H38O8 (466.2566548)


   

6-acetoxy litophynin E

6-acetoxy litophynin E

C26H42O7 (466.2930382)


   
   

cladieunicellin I

cladieunicellin I

C26H42O7 (466.2930382)


   
   

4-epi-aubergenone 11-O-2,3-di-O-acetyl-alpha-L-rhamnopyranoside

4-epi-aubergenone 11-O-2,3-di-O-acetyl-alpha-L-rhamnopyranoside

C25H38O8 (466.2566548)


   

4-epi-aubergenone 11-O-2,4-di-O-acetyl-alpha-L-rhamnopyranoside

4-epi-aubergenone 11-O-2,4-di-O-acetyl-alpha-L-rhamnopyranoside

C25H38O8 (466.2566548)


   

2beta,8-diangeloyloxy-3beta,4beta-epoxy-1beta,10,11-trihydroxybisabol-7(14)-ene

2beta,8-diangeloyloxy-3beta,4beta-epoxy-1beta,10,11-trihydroxybisabol-7(14)-ene

C25H38O8 (466.2566548)


   

2beta,8-diangeloyloxy-1beta,3beta,4alpha,11-tetrahydroxybisabol-7(14),9-diene

2beta,8-diangeloyloxy-1beta,3beta,4alpha,11-tetrahydroxybisabol-7(14),9-diene

C25H38O8 (466.2566548)


   

(22Z)-3,4-seco-9betaH-lanosta-4(28),7,22,24-tetraen-26,23-olid-3-oic acid

(22Z)-3,4-seco-9betaH-lanosta-4(28),7,22,24-tetraen-26,23-olid-3-oic acid

C30H42O4 (466.30829320000004)


   
   

(11S,12S)-4-methyl-11,12-epoxy-2-hydroxy-3-oxoursa-1,4-dine-28-oic acid-gamma-lactone|ulmoidol A

(11S,12S)-4-methyl-11,12-epoxy-2-hydroxy-3-oxoursa-1,4-dine-28-oic acid-gamma-lactone|ulmoidol A

C29H38O5 (466.2719098)


   

23-hydroxy-3-oxomariessia-7,14,24-trien-26,23-olide

23-hydroxy-3-oxomariessia-7,14,24-trien-26,23-olide

C30H42O4 (466.30829320000004)


   

litophynin I monoacetate

litophynin I monoacetate

C26H42O7 (466.2930382)


   
   

O-3-(beta-methyl)valeroyl alpha-bisabolol beta-D-fucopyranoside

O-3-(beta-methyl)valeroyl alpha-bisabolol beta-D-fucopyranoside

C27H46O6 (466.3294216)


   

23-hydroxy-3-oxomariessia-8(9),14,24-trien-26,23-olide

23-hydroxy-3-oxomariessia-8(9),14,24-trien-26,23-olide

C30H42O4 (466.30829320000004)


   

(5R,20R)-23-hydroxy-8(14?13R)-abeo-17,13-friedo-3-oxolanosta-8,14(30),24-triene-26,23-olide|(5R,20R)-23-hydroxyl-8(14?13R)-abeo-17,13-friedo-3-oxolanosta-8,14(30), 24-triene-26,23-olide

(5R,20R)-23-hydroxy-8(14?13R)-abeo-17,13-friedo-3-oxolanosta-8,14(30),24-triene-26,23-olide|(5R,20R)-23-hydroxyl-8(14?13R)-abeo-17,13-friedo-3-oxolanosta-8,14(30), 24-triene-26,23-olide

C30H42O4 (466.30829320000004)


   
   

(24E,13R)-8(14->13)-abeo-17,13-friedo-lanosta-3,23-dion-8,14(30),24-trien-27-oic acid|neoabiestrine F

(24E,13R)-8(14->13)-abeo-17,13-friedo-lanosta-3,23-dion-8,14(30),24-trien-27-oic acid|neoabiestrine F

C30H42O4 (466.30829320000004)


   

23-hydroxy-8(14?13)-abeo-17,13-fried-3-oxolanosta-8,14(15),24-triene-26,23-olide

23-hydroxy-8(14?13)-abeo-17,13-fried-3-oxolanosta-8,14(15),24-triene-26,23-olide

C30H42O4 (466.30829320000004)


   

(23R,24S)-3beta,11alpha,16beta,23,24-pentahydroxy-5alpha-cholestan-6-one

(23R,24S)-3beta,11alpha,16beta,23,24-pentahydroxy-5alpha-cholestan-6-one

C27H46O6 (466.3294216)


   

2-(3-eicosadienoyloxy-2-hydroxypropanoxy)methylpropenoic acid

2-(3-eicosadienoyloxy-2-hydroxypropanoxy)methylpropenoic acid

C27H46O6 (466.3294216)


   

(2alpha, 3beta, 5alpha, 6beta, 9alpha, 11alpha)-Cholest-7-ene-2, 3, 5, 6, 9, 11-hexol

(2alpha, 3beta, 5alpha, 6beta, 9alpha, 11alpha)-Cholest-7-ene-2, 3, 5, 6, 9, 11-hexol

C27H46O6 (466.3294216)


   
   

ent-manool-13-O-beta-D-2-acetylxylopyranoside

ent-manool-13-O-beta-D-2-acetylxylopyranoside

C27H46O6 (466.3294216)


   

2beta,3beta,14,20,22,25-hexahydroxy-5-cholest-7-ene

2beta,3beta,14,20,22,25-hexahydroxy-5-cholest-7-ene

C27H46O6 (466.3294216)


   

23-Nor-6-oxopristimerol

23-Nor-6-oxopristimerol

C29H38O5 (466.2719098)


   

(rel-5S,6R,8R,9R,10S,13S,15R)-6-acetoxy-9,13:15,16-diepoxy-15-methoxylabdane|3alpha,8beta-diacetoxy-9,13;15,16-diepoxy-15beta-methoxylabdan-7-one|leosibirinone A

(rel-5S,6R,8R,9R,10S,13S,15R)-6-acetoxy-9,13:15,16-diepoxy-15-methoxylabdane|3alpha,8beta-diacetoxy-9,13;15,16-diepoxy-15beta-methoxylabdan-7-one|leosibirinone A

C25H38O8 (466.2566548)


   

23-oxo-mariesiic acid B|Mariesiic acid C

23-oxo-mariesiic acid B|Mariesiic acid C

C30H42O4 (466.30829320000004)


   
   

(3R,28R)-3,28-dihydroxy-1,12,18,29-triacontatetrayne-14,17-dione|14,17-Diketone-1,12,18,29-Triacontatetrayne-3,14,17,28-tetrol

(3R,28R)-3,28-dihydroxy-1,12,18,29-triacontatetrayne-14,17-dione|14,17-Diketone-1,12,18,29-Triacontatetrayne-3,14,17,28-tetrol

C30H42O4 (466.30829320000004)


   
   

cryptosphaerolide

cryptosphaerolide

C26H42O7 (466.2930382)


   

alpha-eudesmol-beta-D-glucopyranoside-6-O-tiglate

alpha-eudesmol-beta-D-glucopyranoside-6-O-tiglate

C26H42O7 (466.2930382)


   
   
   

methyl 15-Z cinnamoyloxy-7-labden-17-oate

methyl 15-Z cinnamoyloxy-7-labden-17-oate

C30H42O4 (466.30829320000004)


   

ent-manool-13-O-beta-D-3-acetylxylopyranoside

ent-manool-13-O-beta-D-3-acetylxylopyranoside

C27H46O6 (466.3294216)


   

(-)-3,16-dioxolanosta-8,24-dien-21-oic acid|pinicolic acid B

(-)-3,16-dioxolanosta-8,24-dien-21-oic acid|pinicolic acid B

C30H42O4 (466.30829320000004)


   

(22E,24R)-5alpha-cholest-22-ene-3beta,4beta,6alpha,8,15beta,24-hexaol

(22E,24R)-5alpha-cholest-22-ene-3beta,4beta,6alpha,8,15beta,24-hexaol

C27H46O6 (466.3294216)


   

4,5,6-Tri-O-acetyl hygrophorone B14

4,5,6-Tri-O-acetyl hygrophorone B14

C26H42O7 (466.2930382)


   

tirucalla-7,25(26)-diene-3,24-dion-21,16-olide

tirucalla-7,25(26)-diene-3,24-dion-21,16-olide

C30H42O4 (466.30829320000004)


   

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-12-ol|Usambaridin Vi

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-12-ol|Usambaridin Vi

C30H34N4O (466.2732474)


   
   
   
   

Wilforol A

(2R,4aS,6aS,12bR,14aS,14bR)-10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-8-oxo-1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid

C29H38O5 (466.2719098)


Wilforol A is a pentacyclic triterpenoid with formula C29H38O5, originally isolated from the stems of Tripterygium regelii. It has a role as a plant metabolite. It is a pentacyclic triterpenoid, a hydroxy monocarboxylic acid, a member of catechols, a cyclic terpene ketone and an enone. Wilforol A is a natural product found in Tripterygium hypoglaucum, Tripterygium wilfordii, and Celastrus orbiculatus with data available. A pentacyclic triterpenoid with formula C29H38O5, originally isolated from the stems of Tripterygium regelii.

   

Lindokaurenosid C

Lindokaurenosid C

C26H42O7 (466.2930382)


   

5??,6??-Epoxy-4??-hydroxy-1-oxo-witha-2,16,24-trienolide

5??,6??-Epoxy-4??-hydroxy-1-oxo-witha-2,16,24-trienolide

C29H38O5 (466.2719098)


   

(16R,23S)-3-oxo-16,23-epoxylanosta-7,24-dien-26,23-olide

(16R,23S)-3-oxo-16,23-epoxylanosta-7,24-dien-26,23-olide

C30H42O4 (466.30829320000004)


   
   

(2S)-OMPT

(2S)-3-[(hydroxymercaptophosphinyl)oxy]-2-methoxypropyl ester, 9Z-octadecenoic acid, triethyl ammonium salt

C22H43O6PS (466.25178280000006)


   

6-Oxo-23-norpristimerol

6-Oxo-23-norpristimerol

C29H38O5 (466.2719098)


   
   

C23H38N4O6_1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N~2~-methylalaninamide

NCGC00381111-01_C23H38N4O6_1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N~2~-methylalaninamide

C23H38N4O6 (466.2791208)


   
   

10-hydroxyusambarine

10-hydroxyusambarine

C30H34N4O (466.2732474)


   

11-hydroxyusambarine

11-hydroxyusambarine

C30H34N4O (466.2732474)


   

(6R)-2-(hydroxymethyl)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(6R)-2-(hydroxymethyl)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

(6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

(2S,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(2S,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

(2R,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(2R,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

"(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid"

C27H46O6 (466.3294216)


   

His Ile Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

His Ile Thr Pro

(2S)-1-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

His Ile Val Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylbutanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

His Leu Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

His Leu Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

His Leu Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylbutanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

His Pro Ile Thr

(2S,3R)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

His Pro Leu Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

His Pro Thr Ile

(2S,3S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

His Pro Thr Leu

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-4-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

His Thr Ile Pro

(2S)-1-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

His Thr Leu Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

His Thr Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

His Thr Pro Leu

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

His Val Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylpentanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

His Val Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

His Val Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H38N6O5 (466.2903538)


   

His Val Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H38N6O5 (466.2903538)


   

Ile His Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

Ile His Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Ile His Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Ile Pro His Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

Ile Pro Thr His

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Ile Thr His Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Ile Thr Pro His

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Ile Val His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Ile Val Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H38N6O5 (466.2903538)


   

Leu His Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

Leu His Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Leu His Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Leu Pro His Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C21H34N6O6 (466.2539704)


   

Leu Pro Thr His

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Leu Thr His Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Leu Thr Pro His

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Leu Val His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Leu Val Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H38N6O5 (466.2903538)


   

Pro His Ile Thr

(2S,3R)-3-hydroxy-2-[(2S,3S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]butanoic acid

C21H34N6O6 (466.2539704)


   

Pro His Leu Thr

(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]butanoic acid

C21H34N6O6 (466.2539704)


   

Pro His Thr Ile

(2S,3S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Pro His Thr Leu

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-4-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Pro Ile His Thr

(2S,3R)-3-hydroxy-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]butanoic acid

C21H34N6O6 (466.2539704)


   

Pro Ile Thr His

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Pro Leu His Thr

(2S,3R)-3-hydroxy-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]butanoic acid

C21H34N6O6 (466.2539704)


   

Pro Leu Thr His

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Pro Thr His Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Pro Thr His Leu

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Pro Thr Ile His

(2S)-2-[(2S,3S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Pro Thr Leu His

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Thr His Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Thr His Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Thr His Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Thr His Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Thr Ile His Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Thr Ile Pro His

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Thr Leu His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H34N6O6 (466.2539704)


   

Thr Leu Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Thr Pro His Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Thr Pro His Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H34N6O6 (466.2539704)


   

Thr Pro Ile His

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Thr Pro Leu His

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H34N6O6 (466.2539704)


   

Val His Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Val His Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Val His Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H38N6O5 (466.2903538)


   

Val His Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H38N6O5 (466.2903538)


   

Val Ile His Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Val Ile Val His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H38N6O5 (466.2903538)


   

Val Leu His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C22H38N6O5 (466.2903538)


   

Val Leu Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H38N6O5 (466.2903538)


   

Val Val His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C22H38N6O5 (466.2903538)


   

Val Val His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C22H38N6O5 (466.2903538)


   

Val Val Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H38N6O5 (466.2903538)


   

Val Val Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H38N6O5 (466.2903538)


   

(24RS)-28,28,28-trifluoro-25-hydroxyvitamin D2 / (24RS)-28,28,28-trifluoro-25-hydroxyergocalciferol

(24RS)-28,28,28-trifluoro-25-hydroxyvitamin D2 / (24RS)-28,28,28-trifluoro-25-hydroxyergocalciferol

C28H41F3O2 (466.3058482)


   

(5Z,7E)-(1S,3R)-24-(dimethoxyphosphoryl)-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-24-(dimethoxyphosphoryl)-25,26,27-trinorvitamin D3 / 1α-hydroxy-24-(dimethoxyphosphoryl)-25,26,27-trinorcholecalciferol

C26H43O5P (466.28479580000004)


   

24,24-difluoro-1α,25-dihydroxy-24a-homovitamin D3 / 24,24-difluoro-1α,25-dihydroxy-24a-homocholecalciferol

24,24-difluoro-1α,25-dihydroxy-24a-homovitamin D3 / 24,24-difluoro-1α,25-dihydroxy-24a-homocholecalciferol

C28H44F2O3 (466.32583379999994)


   

2β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid

2β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3α,7α,12α,22-Tetrahydroxy-5β-cholestan-26-oic acid

3α,7α,12α,22-Tetrahydroxy-5β-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3α,7α,12α,24-Tetrahydroxy-5α-cholestan-26-oic acid

3α,7α,12α,24-Tetrahydroxy-5α-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3α,7α,12α,23-Tetrahydroxy-5β-cholestan-26-oic acid

3α,7α,12α,23-Tetrahydroxy-5β-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

1β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid

1β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3α,6α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid

3α,6α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3α,7α,12α,25-Tetrahydroxy-5β-cholestan-26-oic acid

3α,7α,12α,25-Tetrahydroxy-5β-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3α-hydroxy-5α-androstane-17-one 3-D-glucuronide

3α-hydroxy-5α-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2566548)


   
   

5-alpha-Dihydrotestosterone glucuronide

5-alpha-Dihydrotestosterone glucuronide

C25H38O8 (466.2566548)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3alpha-Hydroxy-5alpha-androstane-17-one 3-D-glucuronoside

3alpha-Hydroxy-5alpha-androstane-17-one 3-delta-glucuronoside

C25H38O8 (466.2566548)


   

PA(20:0/0:0)

1-eicosanoyl-glycero-3-phosphate

C23H47O7P (466.3059242)


   

2beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

2beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,22-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,12alpha,22-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,24-Tetrahydroxy-5alpha-cholestan-26-oic acid

3alpha,7alpha,12alpha,24-Tetrahydroxy-5alpha-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,23-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,12alpha,23-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

1beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

1beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,6alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,6alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,25-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,12alpha,25-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,22S-trihydroxy-5alpha-cholestan-26-oic acid

3alpha,7alpha,22S-trihydroxy-5alpha-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,26-tetrahydroxy-5alpha-cholestan-27-oic acid

3alpha,7alpha,12alpha,26-tetrahydroxy-5alpha-cholestan-27-oic acid

C27H46O6 (466.3294216)


   

(25R)-1beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid

(25R)-1beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

(25S)-2beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid

(25S)-2beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,22S-tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,12alpha,22S-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

(25S)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid

(25S)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

(25R)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid

(25R)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

(25S)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid

(25S)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

(25R)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid

(25R)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestan-27-oic acid

3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestan-27-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,15alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,15alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,16alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,16alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,16alpha,24R-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,16alpha,24R-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha,7alpha,12alpha,16alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,12alpha,16alpha-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

3alpha-hydroxy-5alpha-androstane-17-one 3-D-glucuronide

3alpha-hydroxy-5alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2566548)


   

6-Bromo-5E,9Z,13Z,24Z-heptacosatetraenoic acid

6-Bromo-5E,9Z,13Z,24Z-heptacosatetraenoic acid

C26H43BrO2 (466.2446238)


   

Sarcoehrendin F

methyl 18-oxo-9S,hydroxy-11R,15S-diacetoxy-5Z,13E-prostadienoate

C25H38O8 (466.2566548)


   

LPA 20:0

1-eicosanoyl-glycero-3-phosphate

C23H47O7P (466.3059242)


   

ST 27:1;O6

26-nor-24-methyl-5alpha-cholest-22E-en-3beta,4,6alpha,8beta,15beta,26-hexol

C27H46O6 (466.3294216)


   

Nannosterol B

3beta,15beta,18,24R,25-pentahydroxy-5-alpha-cholestan-7-one

C27H46O6 (466.3294216)


   

ST 29:7;O5

3-oxo-18-acetoxywitha-1,4,24-trienolide

C29H38O5 (466.2719098)


   

(24RS)-28,28,28-trifluoro-25-hydroxyvitamin D2

(5Z,7E,22E)-(3S,24RS)-28,28,28-trifluoro-9,10-seco-5,7,10(19),22-ergostatetraene-3,25-diol

C28H41O2F3 (466.3058482)


   

1alpha-hydroxy-24-(dimethoxyphosphoryl)-25,26,27-trinorvitamin D3

(5Z,7E)-(1S,3R)-24-(dimethoxyphosphoryl)-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C26H43O5P (466.28479580000004)


   

24,24-difluoro-1alpha,25-dihydroxy-24a-homovitamin D3

(5Z,7E)-(1S,3R)-24,24-difluoro-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol

C28H44O3F2 (466.32583379999994)


   

ST 19:1;O2;GlcA

17beta-hydroxy-androstan-3-one 17-O-glucuronide

C25H38O8 (466.2566548)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

cholesteryl sulfate

cholest-5-en-3beta-yl hydrogen sulfate

C27H46O4S (466.31166360000003)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

S-Chinensen F

Ethyl 2″-(5-hydroxy-3S′-methyl-3′-geranylgeranyl-2H-chromen-1-yl)acetate

C30H42O4 (466.30829320000004)


   

R-Chinensen F

Ethyl 2-(5-hydroxy-3R-methyl-3-geranylgeranyl-2H-chromen-1-yl)acetate

C30H42O4 (466.30829320000004)


   

butyl prop-2-enoate,2-methylprop-2-enoic acid,propane-1,2-diol,prop-2-enoic acid,styrene

butyl prop-2-enoate,2-methylprop-2-enoic acid,propane-1,2-diol,prop-2-enoic acid,styrene

C25H38O8 (466.2566548)


   

Buterizine

Buterizine

C31H38N4 (466.3096308)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

Trefentanil

Trefentanil

C25H31FN6O2 (466.24923979999994)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

3,3-(Ethane-1,2-diylbis(oxy))bis(3,1-phenylene)diboronic acid, pinacol ester

3,3-(Ethane-1,2-diylbis(oxy))bis(3,1-phenylene)diboronic acid, pinacol ester

C26H36B2O6 (466.26978560000003)


   

U-73343

U-73343

C29H42N2O3 (466.31952620000004)


U-73343, works as a protonophore, is an inactive analog of U-73122 and can be used as a negative control. U-73343 dose-dependently inhibits acid secretion irrespective of the stimulant. U-73122 is a phospholipase C (PLC) and 5-LO (5-lipoxygenase) inhibitor with an IC50 of 1-2.1 μM for PLC[1][2].

   

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol

C24H39ClN4O3 (466.2710534)


   
   

4-[2-[5-[4-(Diethylamino)phenyl]-4,5-dihydro-1-phenyl-1H-pyrazol-3-yl]vinyl]-N,N-diethylaniline

4-[2-[5-[4-(Diethylamino)phenyl]-4,5-dihydro-1-phenyl-1H-pyrazol-3-yl]vinyl]-N,N-diethylaniline

C31H38N4 (466.3096308)


   
   
   

1-BENZYL-1,6-DIAZASPIRO[3.3]HEPTANE

1-BENZYL-1,6-DIAZASPIRO[3.3]HEPTANE

C26H34N4O4 (466.25799240000003)


   
   

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

C27H46O4S (466.31166360000003)


   

5-S-[2-(Decylamino)ethyl]-5-Thioadenosine

5-S-[2-(Decylamino)ethyl]-5-Thioadenosine

C22H38N6O3S (466.2725958)


   

[[Cyclohexanesulfonyl-glycyl]-3[pyridin-4-YL-aminomethyl]alanyl]piperidine

[[Cyclohexanesulfonyl-glycyl]-3[pyridin-4-YL-aminomethyl]alanyl]piperidine

C22H36N5O4S+ (466.24878760000007)


   

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

(3S,5R,6S)-6-{[(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase.

   

5alpha-Androstan-17beta-ol-3-one glucosiduronate

6-({2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2566548)


   
   

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C25H38O8 (466.2566548)


   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

C25H38O8 (466.2566548)


   

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C25H38O8 (466.2566548)


   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

C25H38O8 (466.2566548)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C22H45NO7P+ (466.29334900000003)


   

N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-4-piperidinecarboxamide

N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-4-piperidinecarboxamide

C28H42N4O2 (466.3307592)


   

Etiocholanolone 3-glucuronide

Etiocholanolone 3-glucuronide

C25H38O8 (466.2566548)


A steroid glucosiduronic acid having etiocholanolone as the steroid component.

   

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-10-ol

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732474)


   

N-(1-Cyclohexylcarbamoyl-cyclopentyl)-N-(5-methyl-isoxazol-3-yl)-N-phenyl-succinamide

N-(1-Cyclohexylcarbamoyl-cyclopentyl)-N-(5-methyl-isoxazol-3-yl)-N-phenyl-succinamide

C26H34N4O4 (466.25799240000003)


   
   

(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid

(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

Glucosyl-6beta-hydroxytestosterone

Glucosyl-6beta-hydroxytestosterone

C25H38O8 (466.2566548)


A steroid saponin that is 6beta-hydroxytestosterone attached to a alpha-D-glucopyranosyl residue at position 6 via glycosidic linkage.

   

Methyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-L-leucinate

Methyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-L-leucinate

C27H34N2O5 (466.24675940000003)


   

(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

C27H46O6 (466.3294216)


   

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.25799240000003)


   

(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.25799240000003)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.25799240000003)


   

(2R)-2-[(4S,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2R)-2-[(4S,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(2R)-2-[(4R,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2R)-2-[(4R,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(2S)-2-[(4S,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2S)-2-[(4S,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501298)


   

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-9-ol

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732474)


   

(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

C27H46O6 (466.3294216)


   

(24S)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid

(24S)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid with S configuration at C-24.

   

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-pentadec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-pentadec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C23H49NO6P+ (466.32973240000007)


   

1-Arachidoylglycerol 3-phosphate

1-Arachidoylglycerol 3-phosphate

C23H47O7P (466.3059242)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) decanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) decanoate

C22H43O8P (466.2695408)


   

2,3-dihydroxypropyl [3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropyl] hydrogen phosphate

2,3-dihydroxypropyl [3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropyl] hydrogen phosphate

C22H43O8P (466.2695408)


   

[3-Hydroxy-2-(octanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(octanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

[3-Hydroxy-2-(propanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(propanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

(2-Acetamido-3-hydroxypentadecyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Acetamido-3-hydroxypentadecyl) 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

[2-(Butanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Butanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

[2-(Heptanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Heptanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

[2-(Hexanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hexanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

[3-Hydroxy-2-(pentanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

[3-Hydroxy-2-(nonanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(nonanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

C22H47N2O6P (466.3171572)


   

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexadecanoate

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexadecanoate

C22H43O8P (466.2695408)


   

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C22H43O8P (466.2695408)


   

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

C22H43O8P (466.2695408)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) undecanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) undecanoate

C22H43O8P (466.2695408)


   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

C22H43O8P (466.2695408)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate

C22H43O8P (466.2695408)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

C22H43O8P (466.2695408)


   

7-Tert-butyl-7-(2,4,6-triisopropylphenyl)-2,3,5,6-dibenzo-7-silanorbornadiene

7-Tert-butyl-7-(2,4,6-triisopropylphenyl)-2,3,5,6-dibenzo-7-silanorbornadiene

C33H42Si (466.3055612)


   

(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid

C27H46O6 (466.3294216)


   

[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C26H44NO6+ (466.31684640000003)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C22H45NO7P+ (466.29334900000003)


   

N-[(E,4Z,7R)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2H-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-enyl]-N-methylacetamide

N-[(E,4Z,7R)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2H-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-enyl]-N-methylacetamide

C25H39ClN2O4 (466.2598204)


   

2-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C22H45NO7P+ (466.29334900000003)


   

[1-carboxy-3-[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C26H44NO6+ (466.31684640000003)


   

2-[hydroxy-[2-hydroxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C23H49NO6P+ (466.32973240000007)


   

Androsterone glucuronide

3alpha-hydroxy-5alpha-androstan-17-one 3-D-glucuronide

C25H38O8 (466.2566548)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Etiocholanolone glucuronide

3alpha-hydroxy-5beta-androstan-17-one 3-D-glucuronide

C25H38O8 (466.2566548)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   
   
   

1-Icosanoyl-sn-glycero-3-phosphate

1-Icosanoyl-sn-glycero-3-phosphate

C23H47O7P (466.3059242)


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as icosanoyl (arachidoyl).

   

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2566548)


   

3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid

3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid

C27H46O6 (466.3294216)


   

Hirsutalin H, (rel)-

Hirsutalin H, (rel)-

C26H42O7 (466.2930382)


A natural product found in Cladiella hirsuta.

   

5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)

5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)

C25H38O8 (466.2566548)


A steroid glucosiduronic acid that is 5alpha-dihydrotestosterone having a single beta-D-glucuronic acid residue attached at position 17.

   

androsterone 3-glucosiduronic acid

androsterone 3-glucosiduronic acid

C25H38O8 (466.2566548)


A steroid glucosiduronic acid having androsterone as the steroid component.

   

3alpha-hydroxy-5beta-androstan-17-one 3-glucosiduronic acid

3alpha-hydroxy-5beta-androstan-17-one 3-glucosiduronic acid

C25H38O8 (466.2566548)


   

TG(24:2)

TG(6:0_6:0_12:2)

C27H46O6 (466.3294216)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

LPEt(18:0)

LPEt(18:0)

C23H47O7P (466.3059242)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

LPG P-16:1 or LPG O-16:2

LPG P-16:1 or LPG O-16:2

C22H43O8P (466.2695408)


   
   
   
   
   
   
   
   
   
   

LP-211

LP-211

C30H34N4O (466.2732474)


LP-211 is a selective and blood?brain barrier penetrant 5-HT7 receptor agonist, with a Ki of 0.58 nM, with high selectivity over 5-HT1A receptor (Ki, 188 nM) and D2 receptor (Ki, 142 nM).

   

Mutant IDH1 inhibitor

Mutant IDH1 inhibitor

C25H34N6O3 (466.2692254)


Mutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM.

   

(5z)-5-[(2r)-2-[(6br,9r,11bs)-10-hydroxy-4,4,6b,10,11b-pentamethyl-3-oxo-1h,2h,4ah,5h,6h,7h,8h,9h,10ah,11h-cyclohexa[a]fluoren-9-yl]propylidene]-3-methylfuran-2-one

(5z)-5-[(2r)-2-[(6br,9r,11bs)-10-hydroxy-4,4,6b,10,11b-pentamethyl-3-oxo-1h,2h,4ah,5h,6h,7h,8h,9h,10ah,11h-cyclohexa[a]fluoren-9-yl]propylidene]-3-methylfuran-2-one

C30H42O4 (466.30829320000004)


   

2,2'-dimethyl-5,5'-bis[(1s)-1,2,2-trimethylcyclopentyl]-[1,1'-biphenyl]-3,3',4,4'-tetrol

2,2'-dimethyl-5,5'-bis[(1s)-1,2,2-trimethylcyclopentyl]-[1,1'-biphenyl]-3,3',4,4'-tetrol

C30H42O4 (466.30829320000004)


   

3-hydroxy-5-{[4-hydroxy-1-(2-hydroxypropan-2-yl)-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-methyl-5-oxopentanoic acid

3-hydroxy-5-{[4-hydroxy-1-(2-hydroxypropan-2-yl)-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-methyl-5-oxopentanoic acid

C26H42O7 (466.2930382)


   

(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e,5s)-7-hydroxy-5-methylhept-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e,5s)-7-hydroxy-5-methylhept-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C27H46O6 (466.3294216)


   

4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2566548)


   

6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

C29H38O5 (466.2719098)


   

(1s,3s,9r,12s,13s,16r,17r)-8,8,13,17-tetramethyl-16-{1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-7-oxapentacyclo[10.7.0.0¹,³.0³,⁹.0¹³,¹⁷]nonadec-4-en-6-one

(1s,3s,9r,12s,13s,16r,17r)-8,8,13,17-tetramethyl-16-{1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-7-oxapentacyclo[10.7.0.0¹,³.0³,⁹.0¹³,¹⁷]nonadec-4-en-6-one

C30H42O4 (466.30829320000004)


   

3b,5,6,7-tetrahydroxy-1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-3-one

3b,5,6,7-tetrahydroxy-1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-3-one

C27H46O6 (466.3294216)


   

(1s,2s,3s,6s,7s,8s,9s,12r)-12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

(1s,2s,3s,6s,7s,8s,9s,12r)-12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H42O7 (466.2930382)


   

(1r,2r,4as,5'r,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

(1r,2r,4as,5'r,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2566548)


   

6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl 3-(4-hydroxyphenyl)prop-2-enoate

6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719098)


   

1-[(1s,2s)-1,2-bis(acetyloxy)-5-oxocyclopent-3-en-1-yl]pentadecyl acetate

1-[(1s,2s)-1,2-bis(acetyloxy)-5-oxocyclopent-3-en-1-yl]pentadecyl acetate

C26H42O7 (466.2930382)


   

methyl 2-(5-hydroxy-2-{[(6e)-3-methyl-7-{[(1r,5r)-3-methyl-5-(2-methylprop-1-en-1-yl)-4-oxocyclopent-2-en-1-yl]methyl}octa-1,6-dien-3-yl]oxy}phenyl)acetate

methyl 2-(5-hydroxy-2-{[(6e)-3-methyl-7-{[(1r,5r)-3-methyl-5-(2-methylprop-1-en-1-yl)-4-oxocyclopent-2-en-1-yl]methyl}octa-1,6-dien-3-yl]oxy}phenyl)acetate

C29H38O5 (466.2719098)


   

(3s,3as,6as,9s,10r)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

(3s,3as,6as,9s,10r)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2566548)


   

(1r,2r,2''s,4r,4as,5's,6s,8as)-2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

(1r,2r,2''s,4r,4as,5's,6s,8as)-2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C25H38O8 (466.2566548)


   

(3s,5s)-5,6-dihydroxy-2-[(1r,3r,4s,5s,6s)-5-hydroxy-6-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-6-methylhept-1-en-3-yl (2z)-2-methylbut-2-enoate

(3s,5s)-5,6-dihydroxy-2-[(1r,3r,4s,5s,6s)-5-hydroxy-6-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-6-methylhept-1-en-3-yl (2z)-2-methylbut-2-enoate

C25H38O8 (466.2566548)


   

14-(acetyloxy)-5,10-dihydroxy-3-isopropyl-10,14-dimethyl-6-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-11-yl butanoate

14-(acetyloxy)-5,10-dihydroxy-3-isopropyl-10,14-dimethyl-6-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-11-yl butanoate

C26H42O7 (466.2930382)


   

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl (2e)-3-(4-methoxyphenyl)prop-2-enoate

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl (2e)-3-(4-methoxyphenyl)prop-2-enoate

C30H42O4 (466.30829320000004)


   

1-(6-hydroxy-5-methylhept-3-en-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

1-(6-hydroxy-5-methylhept-3-en-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C27H46O6 (466.3294216)


   

5-(2-{10-hydroxy-4,4,6b,10,11b-pentamethyl-3-oxo-1h,2h,4ah,5h,6h,7h,8h,9h,10ah,11h-cyclohexa[a]fluoren-9-yl}propylidene)-3-methylfuran-2-one

5-(2-{10-hydroxy-4,4,6b,10,11b-pentamethyl-3-oxo-1h,2h,4ah,5h,6h,7h,8h,9h,10ah,11h-cyclohexa[a]fluoren-9-yl}propylidene)-3-methylfuran-2-one

C30H42O4 (466.30829320000004)


   

12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H42O7 (466.2930382)


   

6-{2',5',6,6,9a-pentamethyl-7-oxo-2,5,5a,8,9,9b-hexahydro-1h-spiro[cyclopenta[a]naphthalene-3,1'-cyclopentan]-2'-en-5'-yl}-2-methyl-4-oxohept-2-enoic acid

6-{2',5',6,6,9a-pentamethyl-7-oxo-2,5,5a,8,9,9b-hexahydro-1h-spiro[cyclopenta[a]naphthalene-3,1'-cyclopentan]-2'-en-5'-yl}-2-methyl-4-oxohept-2-enoic acid

C30H42O4 (466.30829320000004)


   

5-[(2r)-2-[(1s,5ar,7r,9ar,9bs,11as)-7-hydroxy-1,6,6,9a,11a-pentamethyl-2h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]furan-3-carboxylic acid

5-[(2r)-2-[(1s,5ar,7r,9ar,9bs,11as)-7-hydroxy-1,6,6,9a,11a-pentamethyl-2h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]furan-3-carboxylic acid

C30H42O4 (466.30829320000004)


   

2-{3a,6,6,9a,11a-pentamethyl-2,7-dioxo-1h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid

2-{3a,6,6,9a,11a-pentamethyl-2,7-dioxo-1h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid

C30H42O4 (466.30829320000004)


   

(4s,9s,11s,12r,14r,15r,16s)-12-hydroxy-14-isopropyl-5,5,17-trimethyl-15-(2-methylprop-1-en-1-yl)-21-oxahexacyclo[12.5.1.1⁹,¹².0¹,¹¹.0⁴,⁹.0¹¹,¹⁶]henicos-17-ene-13,20-dione

(4s,9s,11s,12r,14r,15r,16s)-12-hydroxy-14-isopropyl-5,5,17-trimethyl-15-(2-methylprop-1-en-1-yl)-21-oxahexacyclo[12.5.1.1⁹,¹².0¹,¹¹.0⁴,⁹.0¹¹,¹⁶]henicos-17-ene-13,20-dione

C30H42O4 (466.30829320000004)


   

5-[(2r)-2-[(3as,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-5-hydroxy-3-methylfuran-2-one

5-[(2r)-2-[(3as,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-5-hydroxy-3-methylfuran-2-one

C30H42O4 (466.30829320000004)